Literature DB >> 3259150

Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model.

M F Ghilardi1, I Bodis-Wollner, M C Onofrj, M S Marx, A A Glover.   

Abstract

The pattern visual evoked potential (PVEP) and pattern electroretinogram (PERG) were studied in 5 cynomolgus monkeys before and during the development of a parkinsonian syndrome induced by MPTP. The stimuli were vertical bars of four spatial frequencies (0.5, 1.2, 2.5 and 3.5 cycles/degree (cpd) modulated at temporal rates of 1, 4, 6, and 8 Hz. Following MPTP administration, all monkeys developed parkinsonian signs accompanied by changes in the amplitude and latency of the PVEP and PERG. Sinemet L-dopat carbi olopa administration produced temporary recovery of both PVEP and PERG. Two of the monkeys were followed for a prolonged period: 30-40 days after MPTP, the parkinsonian signs showed partial recovery; the PVEP latency and amplitude to 2.5 and 3.5 cpd stimuli and the latency to 1.2 cpd showed improvement but remained abnormal. The latencies of PERGs were normal, but the amplitudes were significantly reduced when stimuli of 2.5 and 3.5 cpd were used. Both PVEP and PERG to 0.5 cpd stimuli returned to normal. No further modifications were seen in the recordings performed 6 months and 1 year later. This study demonstrates (1) that spatial frequency-dependent electrophysiological abnormalities occur in the MPTP-treated monkey, a result previously found in human Parkinson's disease, and (2) that dopamine has a specific function in neurotransmission in the visual system of primates.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259150     DOI: 10.1093/brain/111.1.131

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  15 in total

Review 1.  Retinal melatonin and dopamine in seasonal affective disorder.

Authors:  D A Oren
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG.

Authors:  Anja M Palmowski-Wolfe; Maria Timoner Perez; Stefanie Behnke; Gerhard Fuss; Martin Martziniak; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2006-06-22       Impact factor: 2.379

3.  Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.

Authors:  Ozgül Altintaş; Pervin Işeri; Berna Ozkan; Yusuf Cağlar
Journal:  Doc Ophthalmol       Date:  2007-10-26       Impact factor: 2.379

4.  Simultaneous VEP and PERG investigations in early Parkinson's disease.

Authors:  S Calzetti; A Franchi; G Taratufolo; E Groppi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

5.  The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors:  Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal:  Neurotox Res       Date:  2011-01-14       Impact factor: 3.911

Review 6.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

Review 7.  Dopamine and retinal function.

Authors:  Paul Witkovsky
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

8.  Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study.

Authors:  O Blin; D Mestre; G Masson; G Serratrice
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 9.  Retinopathy in Parkinson Disease.

Authors:  Ivan Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

10.  A single dose of L-DOPA changes perceptual experiences and decreases latent inhibition in Parkinson's disease.

Authors:  Orsolya Györfi; Helga Nagy; Magdolna Bokor; Oguz Kelemen; Szabolcs Kéri
Journal:  J Neural Transm (Vienna)       Date:  2016-10-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.